DE3851268T2 - Zyklische Peptolide. - Google Patents

Zyklische Peptolide.

Info

Publication number
DE3851268T2
DE3851268T2 DE3851268T DE3851268T DE3851268T2 DE 3851268 T2 DE3851268 T2 DE 3851268T2 DE 3851268 T DE3851268 T DE 3851268T DE 3851268 T DE3851268 T DE 3851268T DE 3851268 T2 DE3851268 T2 DE 3851268T2
Authority
DE
Germany
Prior art keywords
peptolides
cyclic
cyclic peptolides
undecapeptide
cyclisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3851268T
Other languages
English (en)
Other versions
DE3851268D1 (de
Inventor
Michael Morris Dreyfuss
Max H Schreier
Hans Tscherter
Roland Wenger
Alexander Dr Haslberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Application granted granted Critical
Publication of DE3851268D1 publication Critical patent/DE3851268D1/de
Publication of DE3851268T2 publication Critical patent/DE3851268T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE3851268T 1987-06-19 1988-06-15 Zyklische Peptolide. Expired - Lifetime DE3851268T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH231787 1987-06-19
CH251787 1987-07-02

Publications (2)

Publication Number Publication Date
DE3851268D1 DE3851268D1 (de) 1994-10-06
DE3851268T2 true DE3851268T2 (de) 1995-01-26

Family

ID=25690129

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851268T Expired - Lifetime DE3851268T2 (de) 1987-06-19 1988-06-15 Zyklische Peptolide.

Country Status (17)

Country Link
US (1) US5116816A (de)
EP (1) EP0296123B1 (de)
JP (1) JP2641256B2 (de)
KR (1) KR970010928B1 (de)
AT (1) ATE110784T1 (de)
AU (1) AU623078B2 (de)
CA (1) CA1338183C (de)
DE (1) DE3851268T2 (de)
ES (1) ES2056954T3 (de)
FI (1) FI87928C (de)
HU (1) HU204101B (de)
IE (1) IE64008B1 (de)
IL (1) IL86789A (de)
MY (1) MY103735A (de)
NZ (1) NZ225071A (de)
PH (1) PH25933A (de)
PT (1) PT87763B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU213553B (en) * 1992-05-25 1997-07-28 Biogal Gyogyszergyar Process for isolating of cyclosporin-a
JP3480848B2 (ja) * 1992-06-19 2003-12-22 タカラバイオ株式会社 環状ペプチドの合成方法
US5260215A (en) * 1992-07-20 1993-11-09 Merck & Co., Inc. Fungal microorganism ATCC 74167 capable of producing cholesterol lowering compounds
US6187547B1 (en) 1993-09-08 2001-02-13 Novartis Ag Assay kit
NZ291168A (en) * 1994-07-27 1998-06-26 Novartis Ag Cyclopeptolides which inhibit expression of adhesion molecules (icam-1, vcam and e-selectin)
JP3089350B2 (ja) * 1995-11-20 2000-09-18 ギルフォード ファーマシューティカルズ インコーポレイテッド シクロフィリンロタマーゼ活性の阻害剤
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US5709797A (en) * 1996-06-05 1998-01-20 Poli Industria Chimica S.P.A. Method of isolating cyclosporins
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'-脱氧-3'-氧代-MeBmt]'环孢菌素制备方法
ATE423130T1 (de) 1997-10-08 2009-03-15 Isotechnika Inc Deuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agenzien
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP2003508512A (ja) 1999-09-08 2003-03-04 ギルフォード ファーマシュウティカルズ インコーポレイテッド 非ペプチド性サイクロフィリン結合化合物とその用途
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US20040147433A1 (en) * 2001-06-14 2004-07-29 Marcus Keep Neuroimmunophilins for selective neuronal radioprotection
DK1435910T3 (da) * 2001-10-19 2009-11-09 Isotechnika Inc Nye cyclosporinanaloge mikroemulsionsprækoncentrater
CA2461740C (en) 2001-10-19 2013-02-12 Isotechnika Inc. Synthesis of cyclosporin analogs
EP1603512A2 (de) * 2003-03-17 2005-12-14 Albany Molecular Research, Inc. Neue cyclosporine
WO2006039163A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
EP1804823A4 (de) * 2004-09-29 2010-06-09 Amr Technology Inc Neue cyclosporin-analoga und ihre pharmazeutischen anwendungen
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
WO2006054801A1 (en) * 2004-11-22 2006-05-26 Astellas Pharma Inc. New cyclic peptide compound
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
EP2337788B1 (de) 2008-10-17 2016-03-23 Wisconsin Alumni Research Foundation Verfahren zur herstellung biologisch aktiver alpha-beta-peptide
WO2010052559A1 (en) * 2008-11-06 2010-05-14 Debio Recherche Pharmaceutique S.A. Cycloundecadepsipeptide compounds and use of said compounds as a medicament
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
PL2651965T3 (pl) 2010-12-15 2019-04-30 Contravir Pharmaceuticals Inc Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3
EP2705856A1 (de) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Verbindungen zur Behandlung von neurodegenerativen Erkrankungen
GB201217560D0 (en) * 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
HUP1500502A2 (en) 2015-10-26 2017-04-28 Rotachrom Tech Kft Process for the purification of cyclosporin-a

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
JPS5665853A (en) * 1979-11-01 1981-06-03 Sankyo Co Ltd Mycoplanesin derivative and its preparation
EP0056782B1 (de) * 1981-01-09 1984-08-01 Sandoz Ag Cyclosporine
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
IL84819A (en) * 1986-12-15 1993-07-08 Lilly Co Eli Antibiotic a10255 complex and factors, process, microorganisms, and production therefor
GB8727807D0 (en) * 1987-11-27 1987-12-31 Lepetit Spa Novel antibiotic compounds named a/16686 factors a'1,a'2 and a'3

Also Published As

Publication number Publication date
MY103735A (en) 1993-09-30
FI882926A0 (fi) 1988-06-17
FI882926A (fi) 1988-12-20
NZ225071A (en) 1991-05-28
IL86789A (en) 1993-02-21
KR970010928B1 (ko) 1997-07-02
DE3851268D1 (de) 1994-10-06
AU623078B2 (en) 1992-05-07
EP0296123A3 (en) 1990-06-20
FI87928C (fi) 1993-03-10
FI87928B (fi) 1992-11-30
JPS6425798A (en) 1989-01-27
EP0296123A2 (de) 1988-12-21
US5116816A (en) 1992-05-26
IE64008B1 (en) 1995-06-28
CA1338183C (en) 1996-03-26
HUT50220A (en) 1989-12-28
ES2056954T3 (es) 1994-10-16
KR890000518A (ko) 1989-03-15
ATE110784T1 (de) 1994-09-15
PH25933A (en) 1991-12-19
IL86789A0 (en) 1988-11-30
AU1812488A (en) 1988-12-22
JP2641256B2 (ja) 1997-08-13
EP0296123B1 (de) 1994-08-31
IE881838L (en) 1988-12-19
PT87763B (pt) 1992-10-30
PT87763A (pt) 1988-07-01
HU204101B (en) 1991-11-28

Similar Documents

Publication Publication Date Title
DE3851268T2 (de) Zyklische Peptolide.
AU588860B2 (en) Improvements in or relating to organic compounds
CA2154170A1 (en) Cyclic imide thione activated polyalkylene oxides
CA2194533A1 (en) Light-curing composite material
LU90842I2 (fr) Mabcampath-alemtuzumab et ses d-riv-s pharmaceutiquement acceptables
ES2110009T3 (es) Derivados de la estreptolisina o.
DK539285A (da) Immunosuppressiv faktor
CA2010739A1 (en) Bipolar voltage to frequency converter
ATE90731T1 (de) De-mannosylteicoplanin-derivate.
IT8921553A0 (it) Convertitore di segnali elettrici analogici sbilanciati in segnali tutto differenziali.
BE853720A (fr) Bouillon de culture indiquant la presence de levure candida et autres champignons
CA2143045A1 (en) Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and process for their preparation
ES2099274T3 (es) Derivados de estreptolisina o.
NZ334073A (en) Process for producing cyclodepsipeptide compounds
FR2603302B1 (fr) Nouvelles souches de bacillus brevis et leur application
DK335288A (da) Peptolidderivater og fremgangsmaade til fremstilling deraf
Boulding Peace education as peace development
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
TR200000683T2 (tr) Bir araç koltuğu mesnet çerçeve yapısı için körük.
ES2053601T3 (es) Agentes de biocontrol fundidos.
FR2405297A1 (fr) Nouveaux antibiotiques et leur preparation
MIREHINK et al. Satellite fungi of manganese-oxidizing bacteria
ES2028304T3 (es) Acelerometro ionicamente conductor.
SU586236A1 (ru) Сва
ES2018581B3 (es) Construccion de conexion de pared y de teja

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8328 Change in the person/name/address of the agent

Free format text: SPOTT WEINMILLER & PARTNER, 80336 MUENCHEN